ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LUPIN NEWS why is Lupin Limited price falling or rising

LUPIN NEWS reasons for why stock price of Lupin Limited is falling or rising

LUPIN Lupin is falling or rising technical reasons

Technical analysis forecast of Lupin Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Lupin LUPIN at this time. Stock is rising and might rise more.

It appears as if Lupin LUPIN gave a large move recently.

Stock of Lupin (LUPIN) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

My analysis of Lupin is bullish for shortterm, and stock might move up till 2076.8 or till 2106.3. Use a stoploss of 2052.19 and if this stock hits its stoploss, then it can fall down till 2027.6

LUPIN Lupin is falling or rising NEWS fundamental reasons

Company Announcement Lupin Limited has informed the Exchange regarding Allotment of 36626 Shares. - NEWS as on 2025-12-10

Company Announcement Lupin Limited has informed the Exchange about ESG Rating by NSE Sustainability Ratings & Analytics Limited. - NEWS as on 2025-12-10

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets". - NEWS as on 2025-12-05

Lupin gets USFDA nod for multiple sclerosis drug Drug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tentative approval from the USFDA for Siponimod Tablets. This new product will be manufactured at Lupin's Pithampur facili - NEWS as on 2025-12-05 indiatimes.com

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States". - NEWS as on 2025-12-04

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne)". - NEWS as on 2025-12-01

Lupin gets USFDA nod for biosimilar drug Lupin gets USFDA approval for Armlupeg, a biosimilar to Neulasta, to treat neutropenia in cancer patients. The drug will be manufactured at Lupin’s Pune facility. Armlupeg aims to reduce infection risk from chemotherapy, and Lupin plans to expand its US bi - NEWS as on 2025-12-01 indiatimes.com

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 28, 2025, titled "Lupin Foundation Earns CRISIL s Highest VO 1A Rating for Excellence in Social Responsibility". - NEWS as on 2025-11-28

Company Announcement Lupin Limited has informed the Exchange about U.S. FDA has conducted an inspection at Company's manufacturing facility located at Goa, India. - NEWS as on 2025-11-24

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 15, 2025, titled "Lupin Announces Closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility - NEWS as on 2025-11-17

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility". - NEWS as on 2025-11-14

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag, India". - NEWS as on 2025-11-12

Company Announcement Lupin Limited has informed the Exchange regarding a press release dated November 08, 2025, titled "Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful - NEWS as on 2025-11-10

More announcements and NEWS

LUPIN Lupin Limited current price & indicator signals

Moving Averages for Lupin Limited

  • 5Day Average: 2073.74
  • 12Day Average: 2073.41
  • 20Day Average: 2058.69
  • 50Day Average: 1995.42
  • 100Day Average: 1974.8
  • 150Day Average: 1974.53
  • 200Day Average: 1983.15

LUPIN Indicators & signals

Indicator MACD (12,26,9)

2064.5, 2042.92, 25.28
Indicator MACD is in positive zone

Indicator ADX (14)

0.78, 20.19, 19.88
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LUPIN Lupin Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Wed Dec 2025 2055.40 2050.80 to 2075.00 0.18% 1.06 times
09 Tue Dec 2025 2051.80 2036.70 to 2073.00 -0.91% 1.05 times
08 Mon Dec 2025 2070.70 2055.10 to 2099.40 -1.34% 1.39 times
05 Fri Dec 2025 2098.80 2083.10 to 2105.00 0.33% 1.07 times
04 Thu Dec 2025 2092.00 2066.30 to 2095.20 0.57% 0.77 times
03 Wed Dec 2025 2080.10 2053.60 to 2102.80 -0.12% 1.21 times
02 Tue Dec 2025 2082.70 2074.50 to 2099.90 0.04% 1.32 times
01 Mon Dec 2025 2081.90 2062.40 to 2107.40 -0.01% 0.83 times
28 Fri Nov 2025 2082.20 2070.40 to 2091.40 0.52% 0.91 times
27 Thu Nov 2025 2071.40 2060.20 to 2083.90 -0.01% 0.76 times
26 Wed Nov 2025 2071.60 2035.30 to 2074.00 1.43% 0.68 times
25 Tue Nov 2025 2042.30 2001.10 to 2052.50 2.14% 1.6 times

Videos related to: LUPIN NEWS why is Lupin Limited price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

LUPIN NEWS why is Lupin Limited price falling or rising

 

Back to top